Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Pharmacology & Therapeutics|January 15, 2023
Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficaciesClara Bourreau, Lucas Treps, Sébastien Faure, et al.
Melanoma Research|May 14, 2015
A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigensBenjamin Chalopin, Laetitia Florenceau, Delphine Fradin, et al.
Physiological Reports|October 28, 2014
Hypomethylation of the promoter of the catalytic subunit of protein phosphatase 2A in response to hyperglycemiaFabiola Tros, Aline Meirhaeghe, Samy Hadjadj, et al.
Molecular Cell|July 10, 2012
XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genesNicolas Le May, Delphine Fradin, Izarn Iltis, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2006
Weight-adjusted genome scan analysis for mapping quantitative trait Loci for menarchal ageAnya Rothenbuhler, Delphine Fradin, Simon Heath, et al.
Clinical Epigenetics|March 20, 2015
The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growthMeriem Ouni, Yasemin Gunes, Marie-Pierre Belot, et al.
Molecular Cancer|April 16, 2020
microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiationMaureen Labbé, Christianne Hoey, Jessica Ray, et al.
Translational Lung Cancer Research|May 22, 2026
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative reviewManon Robert, Chloé Sauzay, Sandrine Théoleyre, et al.
Cancer Immunology, Immunotherapy : CII|August 26, 2025
Soluble PD-L1 (sPD-L1) as a biomarker of durable response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with first-line immune checkpoint inhibitors (ICIs)Adrien Costantini, Paul Takam Kamga, Elvire Pons-Tostivint, et al.
Journal of Biological Methods|January 22, 2025
Reappraisal of the fundamental mechanisms of the sHA14-1 molecule as a Bcl-2/Bcl-XL ligand in the context of anticancer therapy: A cell biological studyAoula Moustapha, Pauline Andreu, François Gonzalvez, et al.
Pageof 5